Biosolutions for Ag, Industrial & Consumers: The Digest’s 2021 Multi-Slide Guide to Novozymes

Just released yesterday, this Novozymes Q1 presentation shows their microbes and industrial enzymes business is off to a good start with solid Q1 results with 3% organic sales growth and strong earnings. Get details on their closing of Microbiome Labs acquisition, new product launches, COVID-18 uncertainty, 2021 outlook, and more.